Delivery Order SPE2DB22D1002-SPE2DB24FLCG5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,345.32 firm fixed-price delivery order covers the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a period of performance through November 20, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,734.40 firm fixed-price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,742.13 Firm Fixed Price Delivery Order contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a performance period through January 6, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award is a delivery order valued at $6,724.36 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a period of performance through June 18, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,287.82 firm fixed-price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, with a period of performance through January 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,000.66 firm fixed-price delivery order is for the supply of XIFAXAN 550 mg tablets, a prescription medication. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,208.56 firm fixed-price delivery order contract covers the supply of XIFAXAN 550 MG TABLET 60S, a prescription medication, with a period of performance through January 8, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,542.83, is a Delivery Order for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The contract has an ultimate completion date of January 23, 2025 and is a Firm Fixed Price arrangement. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This federal contract award, valued at $5,470.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 mg tablets, a prescription medication. It is a Firm Fixed Price Delivery Order contract with a period of performance through November 30, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,868.05 firm fixed-price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FLCG5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,312.99 firm fixed-price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a prescription medication, to support military and government healthcare programs. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military and other federal healthcare institutions. The contract has no set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's significant role as a vendor for federal healthcare programs, particularly within the Department of Defense and Veterans Affairs systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 5/16/24 |